Abstract: Background. Head and neck squamous cell carcinoma (HNSCC) cell lines are important preclinical models in the search for novel and targeted therapies to treat head and neck cancer. Unlike many other cancer types, a wide variety of primary and metastatic HNSCC cell lines are available. An easily accessible guide that organizes important characteristics of HNSCC cell lines would be valuable for the selection of appropriate HNSCC cell lines for in vitro or in vivo studies.
a 60% mortality rate even with standard therapy including radiation, surgery, and/or chemotherapy. 4 Five-year survival is only 40%, primarily because of invasive spread and regional metastasis. 5 Head and neck cancers consistently metastasize to the cervical lymph nodes before spreading to distant sites, such as the lung and liver. Current research is focused on understanding the molecular mechanisms of HNSCC development and progression to facilitate the design of novel therapies that may improve survival.
Immortalized cell lines derived from HNSCC tumors have been an invaluable tool for researchers investigating detailed molecular, biochemical, genetic, and immunological properties of head and neck cancer. Advantages of using cell culture include sample homogeneity, cost, and the avoidance of legal and ethical issues associated with animal experimentation. 6 HNSCC cell lines such as Hep2, Hep3, and KB were some of the first HNSCC tumor cell lines to be developed as early as the 1950s. 7 Establishing HNSCC cell lines has proven challenging. Obstacles include fibroblast overgrowth, long quiescent periods before the cells can be subcultured, and the dependence on feeder layers in primary and secondary cultures. [7] [8] [9] With technical improvements, such as the use of complement-mediated lysis to selectively deplete fibroblasts, mitomycin C-treated mouse 3T3 fibroblast feeder layers, and explant outgrowth followed by differential trypsinization, successful permanent culture of HNSCC cell lines has become more feasible. [9] [10] [11] In fact, more than 300 reported HNSCC cell lines have been established compared with approximately 70, 60, and 10 cell lines derived from breast, colon, and prostate cancers, respectively. [12] [13] [14] 
ESTABLISHMENT OF HNSCC TUMOR CELL LINE
The most popular method for establishing a new HNSCC cell line is called the explant culture method. 15 Establishing a new cancer cell line depends on several factors, with the most important being the method of obtaining the specimen. Surgically removing fresh tumor tissue under aseptic conditions specifically for laboratory use from non-necrotic and uninfected areas greatly increases the success rate of a long-term culture. 16 The fresh specimen may be treated with a triple antibiotic solution consisting of penicillin, streptomycin, and amphotericin B. Minced tumor fragments are grown in minimal culture medium supplemented with amino acids and serum. As the epithelial cells are growing, fibroblasts are routinely removed either with a cell scraper or by differential trypsinization. Differential trypsinization involves adding trypsin to dislodge the fibroblasts under visualization with an inverted microscope and blocking the trypsin activity with serum-containing medium before the epithelial cells detach. An alternative method using a feeder layer was described by Rheinwald and Beckett. 9 Instead of placing minced tumor fragments into culture flasks with medium, the feeder layer method uses culture flasks that contain mitomycin C-treated 3T3 mouse-fibroblast feeder cell monolayers. The feeder cells and fibroblasts are then removed with EDTA inoculations and vigorous pipetting.
CANCER CELL LINE MAINTENANCE
For cancer cells to survive and grow in culture, the in vitro environment must be carefully maintained. Three cell culture conditions that influence tumor cell growth will be discussed: culture medium, culture substrate, and physiochemical variables. Nutrition for the cells is supplied by the medium, either with or without serum. The medium contains amino acids, glucose, vitamins, and salts that are necessary to support cellular functions and cell synthesis. More often than not, serum, a chemically undefined mixture of hormones, growth factors, lipids, transport proteins, enzyme cofactors, and attachment factors, is added to culture medium to promote cell growth. The serum is isolated by removing the supernatant from clotted blood, usually from a calf or a fetal bovine source because of its high content of embryonic growth factors. 17 One needs to weigh the benefits and disadvantages of adding or withholding serum from medium. The major benefit from adding serum is that the proteins and factors in the serum promote faster tumor cell growth; however, these factors and proteins are relatively expensive and not well-defined. They could potentially interfere with experiments that study the effects of specific exogenous growth factors. Additionally, the cell-to-surface interaction is important for cell proliferation. Cancer cell cultures are usually grown as monolayers on polystyrene plastic; however, there are some exceptions, such as the multicellular tumor spheroid and the soft agar models. Tumor cells lose the requirement for anchorage-dependent growth, enabling some cell lines to grow as 3-dimensional spheroids in suspension culture or as suspensions on top of an agar medium. These 2 models, which will be discussed later in this review, may reflect in vivo behavior more accurately and are used to investigate specific tumor cell characteristics such as drug response or metastatic potential. Finally, physiochemical variables, such as the CO 2 concentration and temperature, need to be maintained within certain limits for optimal cell growth. For human cancer cell lines, the optimal temperature is 378C and the preferred CO 2 atmosphere is 5%. 18 Once the conditions for cancer cell culture growth are established, it is important to routinely examine the cell cultures both macroscopically and microscopically for cell morphology, cell density, and the presence of contaminants. Macroscopically, the color and turbidity of the culture medium can describe the cell density or presence of microbiological contaminants. For example, the culture medium often turns from pink to yellow when the cells in culture have depleted the nutrients in the medium. Cloudy culture medium often indicates the presence of bacteria or fungi in the culture. Microscopically, it is important to check for signs of cell deterioration such as granularity around the nucleus and cytoplasmic vacuolation. The interval between changing medium and subculturing cells depends on the rate of growth or metabolism of the cancer cells; cultures that grow more rapidly require more frequent changes. When cells occupy the entire surface of a flask, the monolayer culture is considered confluent, and the cells need to be subcultured to reduce the cell density to a level where the cells can achieve optimal growth. Subculturing cells requires the use of proteolytic enzymes such as trypsin (0.01-0.5%) and/or 1 mM EDTA to break the cell-to-cell and cell-to-substrate interactions, thereby releasing the cells from the monolayer culture into single cell suspensions. These single cell suspensions can be used for future passages, for cryopreservation, or for setting up experiments.
There is a constant risk of contaminating cell cultures with either microbes or different cancer cell lines. Most of this discussion will address microbial contamination (bacteria, fungus, and mycoplasma) and the methods for monitoring and treating them. Bacterial or fungal contamination is often noticed macroscopically as cloudiness in the medium, fuzzy fungal balls, or microscopically as fine granules. Toxic contamination can cause cultured cells to die and slough off the plate surface, often seen as significant movement under low power. Antibiotics, such as penicillin and streptomycin, may be used to treat unique or irreplaceable cultures that have been contaminated; otherwise, it is recommended that the contaminated cultures be discarded. The concern with using antibiotics prophylactically is developing a source of drug-resistant strains of bacteria that can chronically contaminate the cultures. Mycoplasma are small prokaryotes whose presence in cell cultures cannot be noticed macroscopically or microscopically. Often, these microbes grow insidiously and do not kill the host cells. Despite no apparent influence on cultured cell growth or behavior, the presence of mycoplasma may indeed alter any parameter measured in cell culture or in experimental investigations. 19, 20 By depriving the cultured cells of medium components and degrading specific amino acids, mycoplasma can initiate a range of effects such as altering signal transduction, cytokine and growth factor expression, cancer cell growth, and cell membrane composition. 20 A popular choice for detecting mycoplasma contamination is with the use of polymerase chain reaction technology to detect mycoplasma-specific sequences. It is a sensitive and specific option for routinely screening growing cell lines or for testing cell lines newly introduced in the laboratory. To salvage irreplaceable cell lines, three groups of antibiotics (tetracycline, macrolides, quinolones) are effective in treating mycoplasma infections. 20 
CHARACTERISTICS OF HNSCC CELL LINES
The large number of available HNSCC cell lines underscores the importance of categorizing tumor cell line characteristics to help researchers select a cell line that best suits their needs. This review has organized HNSCC cell lines into practical and useful Appendix tables based upon important characteristics. More detailed information regarding specific cell lines and models can be found in the primary references.
Tumor Cell Line Name and Patient Demographics. Appendix Table A1 includes general characteristics and procurement information, such as tumor cell line name, patient data, and TNM stage. The cell lines that are available from the American Type Culture Collection (ATCC) are noted. The table also provides primary references for the cell lines and additional references focused upon chromosomal and molecular genetic characteristics. The genetics references are not intended to be exhaustive, but provide researchers a starting point for further investigation.
HNSCC usually arises in patients with a history of tobacco and/or alcohol use, suggesting that alcohol and the carcinogens found in tobacco synergistically enhance the development of mutations responsible for HNSCC. Furthermore, areas of the upper aerodigestive tract, which are exposed to the highest levels of carcinogens in smokers, also experience high frequencies of HNSCC, further suggesting that changes at the chromosomal level lead to tumorigenesis. 21, 22 As further evidence of the genetic basis for HNSCC, other malignancies such as esophageal and lung cancers, which share a common carcinogenic association to tobacco, have demonstrated deletions in chromosome 3p. [23] [24] [25] [26] [27] [28] [29] [30] In fact, Cowan et al observed that 6 of 10 HNSCC cell lines demonstrated deletions in regions of chromosome 3p that contain tumor suppressor genes. 29, 31 Other studies investigating chromosomal aberrations have reported 11q13 amplification in 20% to 50% of HNSCC cases and its association with poor clinical prognosis and increased metastasis. [32] [33] [34] The 11q13 locus contains genes that code for cyclin D1, 2 members of the fibroblast growth factor family, and cortactin. Overexpression of cyclin D1 and cortactin may play a role in HNSCC tumor progression. 29, [35] [36] [37] [38] Mutations of the TP53 tumor suppressor gene are a well-recognized step in carcinogenesis. Specific TP53 genetic alterations in HNSCC cell lines have been characterized (Appendix Table A2 ). Chromosomal alterations and instability enable the multistep process of genetic changes in HNSCC. 29, [39] [40] [41] Whether the disruption is a loss of function of tumor suppressor genes or overexpression of oncogenes, or an alteration of chromosomal constitution, genetic changes are at the foundation of the series of changes that lead to rapid cell growth, tumor proliferation, and metastatic invasion. The chromosomal and genetic heterogeneity present in the primary tumor remain evident in cell lines despite continued passage in vitro. Further investigations to elucidate the relationship between genetic alterations at the cytogenetic and molecular level with tumor behavior and clinical outcome will continue to be critical. 29, 31 Site of Origin of Tumor Cell Lines. By organizing cell lines according to the site of origin, site-specific characteristics of HNSCC may be investigated with the possibility of developing more specific and targeted therapies. In the past, head and neck cancer has been studied as an aggregate of tumors from different sites in the upper aerodigestive tract. Appendix Table A3 organizes the tumor cell lines on the basis of the anatomic site of origin. The sites of origin are divided into 7 categories: facial skin, nasal/paranasal sinus, oral cavity, oral pharynx, hypopharynx, pharynx, and larynx. As shown in Appendix Table A3 , most of the HNSCC cell lines are derived from tumors that either originated from the oral cavity or the larynx.
Doubling Times of Tumor Cell Lines. Doubling times are an important parameter used to measure the cellular response to experimental changes in culture conditions such as nutrient concentrations, hormones, or drugs 42 (Appendix Table A4 ). From a practical standpoint, knowledge of doubling times facilitates the daily maintenance of HNSCC cell cultures. Experiments can be planned so that cells will be in log phase when they are treated with reagents. The standard cycle of cell growth begins with negligible growth during the lag phase. After trypsinization, the cells adapt to the new environment by replacing elements of the glycocalyx lost during trypsinization, attaching to the substrate and spreading out. Following the lag phase, cells proceed into exponential growth during log phase. This is the optimal time for sampling because the population is most uniform and cell viability is high. The doubling time is measured during this phase. Cells are counted during the log phase, and the average doubling time is determined by plotting the cell counts as a function of time. 43 Another method for measuring doubling time is to calculate the time necessary for the cells to increase twofold in the middle of the log phase. 42 Toward the end of the log phase, adherent cells become confluent, cell division slows, and steady-state equilibrium between cell growth and cell death is achieved in stationary phase. In normal cells, a phenomenon termed contact inhibition has been observed when the cells become confluent during the stationary phase, suggesting that direct contact between neighboring cells reduces cell motility, membrane ruffling, and cell growth. However, HNSCC cell lines with regular culture medium replenishment will continue to proliferate beyond confluence to form multilayers of cells. The decline phase begins when nutrients are depleted and toxic by-products of metabolism accumulate leading to cell death. 42, 44 In Vivo Xenograft Growth of Tumor Cell Lines. Tumor cell lines or explants introduced as xenografts in mice can potentially model complex interactions between the tumor and its host. Despite limitations, there is no current technology or in vitro assay that can predict the activity of antineoplastic drugs as accurately or demonstrate the tumorigenic and metastatic properties of tumors as fully as xenograft animal models. Appendix Table A5 catalogues the HNSCC cell lines that have grown as xenografts in mice. The athymic nude mouse was first described by Pantelouris in 1968. 45 In 1969, Polvsen and Rygaard were the first to xenograft a human colon adenocarcinoma into a nude mouse, and 3 years later, Polvsen and Rygaard were the first to transplant human tumor cells into the nude mouse model. 46, 47 In 1984, Braakhuis et al 48 demonstrated that the nude mouse xenograft model could be used to study head and neck cancer by implanting 130 human head and neck biopsy explants into the subcutaneous tissue of nude mice.
The most commonly used immunodeficient mouse model to study head and neck cancer is the athymic nude mouse, which carries a homozygous nu mutation on mouse chromosome 11 leading to thymic dysgenesis. 46 While the primary immune defect of these mice is T-cell deficiency to prevent graft rejection, the athymic nude mouse is not completely immunodeficient. Although, functional T lymphocytes are effectively absent, B cells, natural killer (NK) cells, and macrophages are still present. Nevertheless, the nude mouse is more immunodeficient than animals that are rendered immunodeficient by artificial thymectomy or by other means of artificial immunosuppression. The benefits of using athymic nude mice include the following: thorough characterization and wide use; lack of hair that allows for visualization of subcutaneously xenografted tumors; immunodeficiency severe enough to support growth of wide range of tumor cells; and availability on different genetic backgrounds. 49 However, the nude mice retain normal levels of NK cells and macrophages. To eliminate NK cell activity and improve tumor establishment, nude mice can be pretreated with cyclophosphamide. 50 A less commonly used immunodeficient mouse model is the severe combined immunodeficiency (SCID) mouse. The benefit of using a SCID mouse is that the more severe immunodeficiency resulting in arrested T-cell and B-cell development allows for a higher percentage of engraftment, more enhanced tumor growth, and less tumor regression. 49 However, the disadvantages of SCID mice are that they experience a high incidence of thymic lymphomas, which may shorten their lifespan, and their severe immunodeficiency makes them harder to maintain. 49, 51 Several considerations need to be appreciated regarding the mouse xenograft model. 52 The xenograft in the mouse can be derived from either a tumor cell line or a patient biopsy explant. Tumor cell lines are histologically homogenous and undifferentiated, which ensures experimental uniformity and reproducibility. A drawback to using tumor cell lines is the concern that as they grow in vitro, they adapt to the culture environment and may develop genetic and phenotypic differences from the original tumor. The benefit of using biopsy explants is that they conserve morphological and molecular markers characteristics better than tumor cell lines; however, the disadvantage is the heterogeneous cell population found in the biopsy specimen and the difficulty associated with xenografting an explant. The site of xenograft implantation is also an important consideration. Most investigators implant HNSCC tumors into the subcutaneous tissue of the abdomen, nape of the neck, or the flank because of the relative ease in monitoring tumor growth and size; however, the subcutaneous implants show a benign growth pattern. Studies with tumor cells implanted into the subcutaneous tissue had difficulty demonstrating any significant invasion of surrounding tissues or metastatic activity. 47, 48, 53, 54 Patients with head and neck cancer often have tumors that aggressively invade local surrounding tissues, so the subcutaneous model has its limitations. Orthotopic xenografts in the floor of mouth have been able to produce tumors that mimic histopathologic growth in the head and neck cancer patient, including invasion into surrounding tissues and spread to cervical lymph nodes. 55, 56 Despite the recent developments of the murine model in head and neck cancer, it is important to recognize the limitations of the mouse xenograft model. Immunodeficient mouse strains have increased susceptibility to viral and bacterial infections, which limits the life span of the xenograft mouse to 4-6 months. In addition, immunodeficient mice have a different immunobiology when compared with the human host, which may result in different mechanisms and rates of tumor progression as well as treatment responses. Although beyond the scope of this review, the development of novel transgenic, knock-out and/or knock-in mice may provide more realistic models of human HNSCC in the setting of an intact immune system.
Tumor Cell Line Growth in Nonmonolayer Cultures. Soft agar growth demonstrates anchorage-independent proliferation potential, a hallmark of transformed cancer cells. Normally, non-neoplastic cells require cell-matrix anchorage to survive; otherwise, a suspension-induced apoptosis known as anoikis occurs. Heterodimeric transmembrane cell surface receptors known as integrins bind to components of the extracellular matrix (ECM), and numerous studies have shown the disruption of these interactions lead to anoikis. [57] [58] [59] [60] [61] [62] However, cancer cells have less stringent requirements for extracellular matrix adhesion, allowing them to resist anoikis and survive in an anchorage-independent manner. This property enables cancer cells to extravasate into lymphatic channels or blood vessels and invade a distant organ. Growth on soft agar becomes a reliable measure of the metastatic capability of tumor cells. 23 and MDA-1483. 23 One challenge with this methodology is that most HNSCC cell lines do not grow in soft agar.
Spheroids offer a useful model of solid tumors because monolayer cultures lack the cell-to-cell interactions characteristic of tumors in vivo. 66 Spheroids are composed of an outer layer of proliferating cells, an inside layer of quiescent cells, and an inner core of necrotic cells. This arrangement reflects the growth pattern on solid tumors in vivo, with proliferating cells found closest to a nutrient and oxygen supply, quiescent cells found slightly farther, and necrotic cells found the farthest from capillaries. [67] [68] [69] [70] [71] [72] [73] [74] [75] There are 2 methods for culturing spheroids. The most popular approach involves the use of spinner flasks. Monolayer cell cultures are trypsinized and seeded in growth medium within spinner flasks. Rotation is achieved by spinning a stir bar in the spinner flask. Factors that affect spheroid formation include the type of cells, cell density at seeding, the rotation speed, the type of culture medium, and the incubation time. The advantage of using spinner flask cultures is the large number of spheroids formed from large-volume cultures and the considerable size of the spheroids. 67, 76 Another method for forming spheroids is to use agar overlay cultures as first described by Yuhas. 77 Tumor cells obtained from confluent monolayer cultures are trypsinized into single-cell suspensions. These suspensions are seeded in a stationary, nonadherent mixture of complete growth medium and agarose. 67 When the spheroids are ready for experiments, it is critically important to select spheroids of the same size since a slight difference in diameter can result in a dramatic volume difference.
Size uniformity can be achieved with the use of a Pasteur pipette and a low-power microscope, or for rapid harvesting of spheroids, the cultures may be filtered through a nylon sieve of decreasing mesh size to segregate spheroids, based on size and leaving the largest spheroids on top. 67 Spheroids may also be cultured from biopsy specimens and such cultures demonstrate ploidy stability suggesting that biopsies cultured in vivo maintain the cellular complexity of tumors in vivo. 85 Spheroid cultures derived from biopsy specimens do not experience the problematic clonal evolution of tumor cell subpopulations that has been attributed to the passage of monolayer cultures grown from biopsy specimens. 86 After a cell line has been passaged several times, there have been questions about its semblance to the original tumor. 85 However, genetic and molecular cytogenetic data show that HNSCC cells in culture closely resemble those in the primary tumors. 87, 88 A 3-dimensional spheroidal culture may be a better representation of the in vivo cellular complexity and heterogeneity found in the microenvironment of a tumor nodule than a monolayer culture. The 3-dimensional arrangement reflects several characteristics of tumor cells in vivo such as the irregular distribution of oxygen and nutrients found in tumor cells in vivo and cellular subpopulations of proliferating, quiescent, and necrotic cells. A model that better mimics tumor heterogeneity and intercellular contact should exhibit a more representative response to drug therapies. For example, studies using spheroid cell cultures have shown large variations in radiation and drug sensitivity, similar to those found with tumors in vivo. 74, [89] [90] [91] [92] [93] [94] Finally, spheroidal cultures are less affected by the culture conditions because of reduced cell-to-cell interactions. 67 A limiting factor to the use of tumor spheroids lies in the difficulty of establishing cell lines that can associate into spheroid clusters. Although both normal and transformed human cells may aggregate, only certain tumor cells will grow as spheroids. This review lists 11 reported HNSCC cell lines out of almost 300 total cell lines that can reassociate into spheroidal clusters. Across a wide range of different cancer types, only 5 of 22 human tumor xenografts and 16 of 27 tumor cell lines formed spheroids.
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SUMMARY
Head and neck cancer remains a significant public health concern. Despite current surgical treatments and adjunctive chemoradiation therapy, 5-year survival rates remain below 50%. This has prompted a greater need for investigating novel and targeted therapies. The use of HNSCC cell M  T1N0M0  7  -UM-SCC-25  M  T3N0M0  7  17  UM-SCC-26  M  T3N1M0  7  17  UM-SCC-27  M  T1N0M0  7  -UM-SCC-28  F  T1N0M0  7  17  UM-SCC-29  M  T3N2aM0  7  17  UM-SCC-30  F  T3N1M0  7  17  UM-SCC-31  M  T3N0M0  7  -UM-SCC-32  M  T3N1M0  7 -80  M  T4N1M0  7  7, 18, 21  UM-SCC-81A  M  T2N0M0  7  24  UM-SCC-81B  M  T2N0M0  7  7, 24  UM-SCC-82A  F  T2N0M0  7  7 -SCC-82B  F  -7  17, 18, 21  UM-SCC-83A  M  -7  7, 24  UM-SCC-83B  M  -7  7, 24  UM-SCC-84  M  T2N0M0  7  -UM-SCC-85  M  -7  -UM-SCC-86  F  -7  24  UM-SCC-87  M  T3N0M0  7  7, 24  UM-SCC-88  F  T3N1M1  7  -UM-SCC-89  M  T3N0M0  7  24  UM-SCC-90  M  T4N3M0  7  7, 24  UM-SCC-91  M  T4N0M0  7 T4N1M0  28  -SCC-25*  M  T2N1  28, 29  7  SCC-35  -T4N0  29, 30  7  SCC-49  -T2N0  30  -SCC-61  -T4N2b  29, 30  7  SCC-66  -T4N0  30  -SCC-68  M  T4N10M0  7  -SCC-71  -T4N1  30  -SCC-73  -T4N0  30  -SCC-74  F  T4N0M0  7  -SCC-76  -T4N0  30  -SCC-182  M  T3N0M0  7  -SCC-200  M  T2N2M0  7  -SCC-203  M  T2N2M0  7  -SCC-210  M  T3N0M0  7  -SCC-213  M  T4N0M0  7  -SCC-220  M  T4N1M0  7  -JSQ-3  -T3N0  29, 31  7  JSQ-13  --32  -SQ-9G  -T3N1  30  7  SQ-20B  -T2N0  29, 30  7  SQ-29  -T3N1  30  -SQ-31  -T2N0  29, 30  7  SQ-38  -T3N0  30  7  SQ-39  -T3N2a  30  -SQ-43  -T1N0  30  -SQ-50  -T4N2  7  -HN-SCC-3  -T3N3bM0  31  -HN-SCC-28  --31  -HN-SCC-29  --32  -HN-SCC-42  --32  -HN-SCC-58  -T4N1M0  31  -HN-SCC-68  --32  -HN-SCC-80  --32  -HN-SCC-104  -T3N3aM0  31  -Table A1 . (Continued). Sex  TNM stage  Reference  Genetics references   HN-SCC-109A  --32  -HN-SCC-131  --31  -HN-SCC-135  -T1N1MO  29  7  HN-SCC-151  -T3N0M0  29  7  HN-SCC-167  -T3N0M0  29  7  HN-SCC-294  -T2N0M0  29  7  PCI-1  M  -33, 34  7, 33  PCI-2  M  T3N0M0  33  7, 33  PCI-3  -T3N0M0  33  7, 33  PCI-4A  M  T3N0M0  33, 34  7, 33  PCI-4B  M  T3N0M0  33, M  T2N1M0  33  -PCI-17  F  T2N0M0  33  -PCI-18  M  -33  -PCI-19  M  T3N0M0  7  -PCI-20  M  -7  -PCI-21  M  T3N2M0  7  -PCI-22A  M  T4N1M0  34, 35  -PCI-22B  M  T4N1M0  34, 35  -PCI-23  F  T2N0M0  36  -PCI-24  M  T2N0M0  33  -PCI-25  M  T4N1M0  34, 35  -PCI-26  M  T3N0M0  34  -PCI-27  M  T4N0M0  7  -PCI-28  M  T3N2M0  34, 35  -PCI-29  F  T4N0M0  7  -PCI-30  M  T3N1M0  34, 36  -PCI-31  M  T3N0M0  34  -PCI-32  M  T4N0M0  37  -PCI-33  M  -34  -PCI-34  M  T4N2M0  34  -PCI-35  M  T3N1M0  7  -PCI-36  F  T2N0M0  34  -PCI-37A  M  T3N2M0  34  -PCI-37B  M  T3N2M0  34  -PCI-38  M  T3N1M0  34, 36  -PCI-39  M  T2N0M0  34  -PCI-40  M  T4N2M0  7  -PCI-41  F  T2N0M0  7  -PCI-42  M  T4N2M0  7  -PCI-43  M  T1N0M0  7  -PCI-44  M  T4N0M0  7  -PCI-45  M  T4N3M0  7  -PCI-46  M  T2N2M0  7  -PCI-47  F  T3N0M0  7  -PCI-50  M  T2N0M0  38  -PCI-51  M  T1N2M0 39 - M  T1N2M0  40  -PCI-100  M  T3N1M0  7  -PCI-101  M  T4N2M0  7  -PCI-102  M  T2N0M0  7  -PCI-103  M  T3N0M0  7  -PCI-104  M  T4N3M0  7  -PCI-105  M  T3N0M0  7  -PCI-106  F  T4N2M0  7  -UT-SCC-1A  F  T2N1M0  19, 41  7  UT-SCC-1B  F  T4N1M0  42  7  UT-SCC-2  M  T4N1M0  19, F  T3N0M0  42  7  UT-SCC-17  M  T2N0M0  7  7  UT-SCC-18  M  T3N1M0  42  7, 43  UT-SCC-19A  M  T4N0M0  44  7, 43  UT-SCC-19B  M  T4N0M0  44  7  UT-SCC-20A  F  T1N0M0  42  7  UT-SCC-20B  F  -42  7  UT-SCC-21  M  T3N0M0  7  7  UT-SCC-22  M  T1N0M0  44  7  UT-SCC-23  M  T3N0M0  7  7  UT-SCC-24A  M  T2N0M0  42  7  UT-SCC-24B  M  T2N0M0  42  7, 43  UT-SCC-25  M  T2N0M0  42  7  UT-SCC-26A  M  T1N2M0  42  7  UT-SCC-26B  M  T1N2M0  42  7  UT-SCC-27  M  T2N0M0  7  7  UT-SCC-28  F  T2N0M0  7  7  UT-SCC-29  M  T2N0M0  42, 44  7, 43  UT-SCC-30  F  T3N1M0  7  7  UT-SCC-31  M  T3N2bM0  7  7  UT-SCC-32  M  T3N0M0  7  7  UT-SCC-33  F  T2N0M0  7  7  UT-SCC-34  M  T4N0M0  7  7  UT-SCC-35  M  T2N0M0  7  7  UT-SCC-36  M  T4N1M0  7  7  UT-SCC-37  F  T2N0M0  7  -UT-SCC-38  M  T2N0M0  7  -UT-SCC-39  M  T2N0M0  7  -UT-SCC-40  M  T3N0M0  7  -UT-SCC-41  M  T3N0M0  7  -UT-SCC-42A  M  T4N3M0  7  -UT-SCC-42B  M  T4N3M0  7  -UT-SCC-43A  F  T4N1M0  7  -UT-SCC-43B  F  T4N1M0  7  -UT-SCC-44  F  T4N2bM0  7  -Table A1 . (Continued). Sex  TNM stage  Reference  Genetics references   UT-SCC-45  M  T3N1M0  7  -UT-SCC-46A  M  T1N0M0  7  -UT-SCC-46B  M  T1N0M0  7  -UT-SCC-47  M  T2N0M0  7  -UT-SCC-48  M  T3N0M0  7  -UT-SCC-49  M  T2N0M0  7  -UT-SCC-50  M  T2N0  7  -UT-SCC-51  M  T2N0M0  7  -UT-SCC-52  M  T2N1M0  7  -UT-SCC-53  M  T4N2cM0  7  -UT-SCC-54A  F  T2N0M0  7 T1N0M0  21  21  HFH-SCC-4  M  T4N0M0  21  21  HFH-SCC-6  M  T2N1M0  21  21, 45  HFH-SCC-8  M  T1N1M0  21  46  HFH-SCC-11  M  T3N0M0  21  21  HFH-SCC-12  M  T2N2bM0  21  21  HFH-SCC-15  F  -21  21  HFH-SCC-16  M  T2N2M0  21  21  HFH-SCC-17  -NS  18  18  HFH-SCC-19  M  T1N2M0  21  21  HFH-SCC-20  M  T4N3M0  21  21  HFH-SCC-28  M  T2N0M0  21  21  HFH-SCC-29  F  -21  21  HFH-SCC-33  M  T4N2M0  21  21  HFH-SCC-42  M  T2N0M0  21  21  AMC-HN-1  M  T1N0M0  47  47  AMC-HN-2  M  T4N2M0  47  47  AMC-HN-3  M  T3N1M0  47  47  AMC-HN-4  F  T4N0M0  47  47  AMC-HN-5  M  T3N0M0  47  47  AMC-HN-6  M  T4N2M0  47  47  AMC-HN-7  M  T4N2M0  47  47  AMC-HN-8  M  T3N2M0  47  47  AMC-HN-9  F  T4N2M0  47  47  UD-SCC-1  M  T3N2bM0  48  48  UD-SCC-2  M  T1N2M0  48  48  UD-SCC-3  M  T2N2cM0  48  48  UD-SCC-4  M  T3N1M0  48  48  UD-SCC-5  M  T1N1M0  7  48  UD-SCC-6  M  T2N0M0  7  48  HNSCCUM-01T  M  T2N2cM0  7  -HNSCCUM-02T  M  T3N3bM0  7  -HNSCCUM-03T  M  T3N2bM0  7  -HNSCCUM-04N  M  T1N1M0  7  -HNSCCUM-05N  M  T1N2bM0  7  -HNSCCUM-06N  M  T2N2cM0  7  -Table A1 . (Continued). Sex  TNM stage  Reference  Genetics references   HNSCCUM-07N  M  T2N2bM0  7  -TU-138  M  T3N0M0  49  -TU-158 LN  M  T2N2aM0  49  -TU-159  M  T3N0M0  49  -TU-167  F  T4N2bM0  49  -TU-177  M  T3N0M0  49  -TU-182  F  T3N2bM0  49  -TU-202  --7  -TU-212  M  T2N2cM0  49  -TU-212 LN  M  T2N2cM0  49  -TU-358B  --7  -TU- 
Cell line
- UT-SCC-54B F T2N0M0 7 - UT-SCC-55 M T4N1M0 7 - EV-SCC-1 M T2N0M0 22 - EV-SCC-2 M T2N2aM0 7 - EV-SCC-3 M T2N2bM0 22 - EV-SCC-4 M T3N1M0 22 - EV-SCC-7 M T4N0M0 7 - EV-SCC-10M M T4N1M0 7 - EV-SCC-14M M T2N2bM0 7 - EV-SCC-17P M T4N0M0 7 - EV-SCC-17M M T4N0M0 7 - EV-SCC-18 M T3N1M0 7 - EV-SCC-19P M T3N1M0 7 - EV-SCC-19M M T3N1M0 7 - HFH-SCC-3 M
